Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,046 public trials 269 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

NCT03486873

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +4 more
Locations
  • Arizona Cancer Center at UMC North ( Site 0018) Tucson, Arizona, United States
  • Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054) Bakersfield, California, United States
  • California Cancer Associates for Research & Excellence ( Site 0016) Fresno, California, United States
  • Providence Medical Foundation ( Site 0087) Fullerton, California, United States
View all 782 locations
View Trial Details
Recruiting

SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)

NCT05375643

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Cancer, +9 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute at St. Elizabeth's Medical Center Brighton, Massachusetts, United States
  • Dana-Farber Cancer Instiute - Merrimack Valley Methuen, Massachusetts, United States
View Trial Details
Recruiting

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

NCT04996875

Conditions
Advanced Systemic Mastocytosis (AdvSM), Aggressive Systemic Mastocytosis (ASM), Bone Marrow Diseases, +35 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 42 locations
View Trial Details
Recruiting

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

NCT07195916

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +29 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • The University of Nebraska Medical Center Omaha, Nebraska, United States
View all 22 locations
View Trial Details

Related conditions